Phillyrin prevents calcium oxalate kidney stones through the PPARγ signaling pathway
Background Nephrolithiasis is a significant health issue causing pain, hypertension, and chronic kidney disease. Phillyrin, a bioactive compound from Forsythia suspensa, may offer therapeutic benefits against these conditions. The study was focused on phillyrin efficacy on alleviating kidney stone f...
Saved in:
| Main Authors: | Xiaohan Chu, Xingkang Chang, Shuaiqi Liu, Shengwei Zhang, Enxu Xie, Bo Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2025.2486559 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GOLPH3 promotes calcium oxalate-induced renal injury and fibrosis through Golgi stress-mediated apoptosis and inflammatory responses
by: Bao-feng Song, et al.
Published: (2025-03-01) -
Gut microbiota-regulated unconjugated bilirubin metabolism drives renal calcium oxalate crystal deposition
by: Shujue Li, et al.
Published: (2025-12-01) -
Lgals3 Promotes Calcium Oxalate Crystal Formation and Kidney Injury Through Histone Lactylation‐Mediated FGFR4 Activation
by: Zehua Ye, et al.
Published: (2025-03-01) -
Study on the Effect of Phillyrin on <i>Streptococcus suis</i> In Vivo and In Vitro
by: Fangyan Yuan, et al.
Published: (2024-12-01) -
Phillyrin ameliorates DSS-induced colitis in mice via modulating the gut microbiota and inhibiting the NF-κB/MLCK pathway
by: Tong Li, et al.
Published: (2025-02-01)